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All cells release a multitude of nanoscale extracellular vesicles (nEVs) into circulation,
offering immense potential for new diagnostic strategies. Yet, clinical translation for
nEVs remains a challenge due to their vast heterogeneity, our insufficient ability to
isolate subpopulations, and the low frequency of disease-associated nEVs in biofluids.
The growing field of nanoplasmonics is poised to address many of these challenges.
Innovative materials engineering approaches based on exploiting nanoplasmonic
phenomena, i.e., the unique interaction of light with nanoscale metallic materials, can
achieve unrivaled sensitivity, offering real-time analysis and new modes of medical and
biological imaging. We begin with an introduction into the basic structure and function
of nEVs before critically reviewing recent studies utilizing nanoplasmonic platforms to
detect and characterize nEVs. For the major techniques considered, surface plasmon
resonance (SPR), localized SPR, and surface enhanced Raman spectroscopy (SERS),
we introduce and summarize the background theory before reviewing the studies applied
to nEVs. Along the way, we consider notable aspects, limitations, and considerations
needed to apply plasmonic technologies to nEV detection and analysis.
Keywords: exosomes, diagnostics, SERS, SPR, nanopillars, nanoarrays
INTRODUCTION
Nanoscale extracellular vesicles (nEVs) encompass a heterogeneous grouping of naturally
occurring nanoparticles that are endogenously secreted by all cells tested to date (Mathieu et al.,
2019). As researchers have begun to unravel the structure and function of these lipid-bilayer
wrapped nanoscale assemblies, numerous analytical technologies have been applied to investigate
nEVs in the context of disease detection and diagnosis (Coumans et al., 2017; Théry et al., 2018).
No category of techniques may have more promise than nanoplasmonics, the field of engineering
nanoscale metallic surfaces for the significant enhancement of analytical signals, both in magnitude
and also in terms of molecular specificity. While promising, nanoplasmonic innovations are
difficult to translate into clinical diagnostic platforms due to both the inherent complexity of
the techniques themselves, but also as a result of the compositional and temporal heterogeneity
of biological agents inside the human body during disease progression. Such heterogeneity is a
particular hallmark of nEVs (Tkach et al., 2018).
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The motivation of this review is to comprehensively describe
the state of the art in plasmonics sensing of nEVs in the context
of disease detection and monitoring. We begin with an overview
of nEV structure and function before assessing the work being
performed at the intersection of nanoplasmonics-based nEV
detection. We finish with a critical overview of the current
positioning of the field. Throughout, we emphasize the challenges
in enriching and analyzing nEVs and carefully consider the
limitations of each presented methodology.
nEV Background and Characteristics
The first descriptions of nEVs involved careful transmission
electron microscopy (TEM) analyses of maturing reticulocytes,
cells that specialize in recycling a large portion of their contents,
and nEVs spent much of the last 30 years associated primarily
with their function in secreting cellular waste (Johnstone et al.,
1987; Raposo et al., 1996). In the early 2000s, a handful
of researchers began to demonstrate the immune-stimulating
effects of nEVs in vivo (Théry et al., 2002). A notable sea-
change soon arose, when it was reported that isolated nEVs
contained, and were capable of delivering, functional RNAs,
establishing a strong physiological relevance (Valadi et al., 2007).
Since this paradigm shift, the field of nEVs has experienced
an exponential growth in published reports describing their
structure and function. Although our understanding continues
to rapidly evolve, it is now well-accepted that nEVs are a highly
diverse and complex group of nanoparticles exhibiting vast
biomolecular heterogeneity and likely contributing to numerous
functions throughout all biological kingdoms, capable of acting
both in their local environment and also released in circulation
(Yáñez-Mo et al., 2015).
Various types of nEVs and their contents have been
implicated in controlling, or at least found to be associated with,
numerous homeostatic processes, including cell viability and
proliferation, cellular differentiation, immunosuppression, bone
formation, modulation of blood pressure, and both promotion
and suppression of angiogenesis (Kusuma et al., 2018). They
are reported to modulate extracellular matrix remodeling to
promote cell intravasation and migration via trafficking of
numerous matrix-remodeling enzymes (Nawaz et al., 2018).
Many of their physiological claims are also associated with
pathological conditions, implicating nEVs as mediators of a host
of cardiovascular and metabolic diseases (Koenen and Aikawa,
Abbreviations: Ab, antibody; AgNC, silver nanocube; AgNP, silver nanoparticle;
AuNI, gold nanoisland; AuNP, gold nanoparticle; AuNR, gold nanorod; AuNS,
gold nanostar; BCA, bicinchoninic acid; CTC, circulating tumor cell; DLS,
dynamic light scattering; ELISA, enzyme-linked immunosorbent assay; EVs,
extracellular vesicles; LOs, large oncosomes; LOD, limit of detection; LOQ,
limit of quantification; LPPs, lipoprotein particles; LSPR, localized surface
plasmon resonance; LTRS, laser trapping Raman spectroscopy; MP-SPR, multi-
parametric SPR; MVs, microvesicles; nEVs, nanoscale extracellular vesicles;
NTA, nanoparticle tracking analysis; OvCa, ovarian cancer; PIA, plasmonic
interferometer array; PSA, prostate-specific antigen; RI, refractive index; RNP,
ribonucleoproteins ; SERS, surface enhanced Raman spectroscopy; SNR, signal-to-
noise ratio; SPR, surface plasmon resonance; SPs, surface plasmons; SPPs, surface
plasmon polaritons; TEIR, total exosome isolation reagent; TEM, transmission
electron microscope; TIR, total internal reflection; UF, ultrafiltration; WB,
Western blot.
2018), arthritis and inflammatory disease (Buzas et al., 2014),
neurological disorders (Coleman and Hill, 2015; Janas et al.,
2016), and cancers. Much effort has been applied to teasing
out the position of nEVs in cancer pathology, namely their
role in pre-metastatic niche formation (Costa-Silva et al., 2015)
via integrin-mediated organotropic targeting (Hoshino et al.,
2015) and followed by attracting/repelling certain populations of
immune cells (Bobrie and Théry, 2013), stimulating angiogenesis
(Aguado et al., 2017), matrix remodeling (Nawaz et al.,
2018), and reprogramming of target cell transcriptomes to
promote tumorigenesis (Melo et al., 2014). The role of nEVs
in host-pathogen communication is also a prevalent topic
(Deatherage and Cookson, 2012; Dauros Singorenko et al., 2017).
Accumulating evidence demonstrates that virus-modified or
virus-containing nEVs contribute to spread and immune evasion,
particularly in the context of promoting cancer (Meckes, 2015).
Many therapeutic claims for nEVs have been introduced, for
example nEVs have been proposed for use in cancer vaccination
(Tan et al., 2010), resistance to viral infection (Gould et al., 2011),
and to challenge demyelinating diseases (Osorio-Querejeta et al.,
2018). Released from mesenchymal stromal cells (MSCs), nEVs
are largely considered as potent cell-free regenerative agents,
found to be effective in bone and tissue repair, and as protective or
curative agents in ischemia, sepsis, renal fibrosis, and osteopenia
(Jing et al., 2018). MSC-nEVs are immune privileged and can
be loaded with exogenous therapeutic agents, therefore there
is much interest in their use as targeted drug delivery agents
(Barile and Vassalli, 2017). While technical issues have presently
prevented scalablemethods to do so effectively, several promising
clinical trials are currently underway (Wilson et al., 2018).
Structural and Molecular Heterogeneity of
nEV Subpopulations
Exosomes are the most well-defined and well-studied nEV
subtype, although the term has come to mean different things
(Gould and Raposo, 2013). Most appropriate may be the
biogenetic usage of the term, i.e., those vesicles originating as
ESCRT-dependent invaginations of early endosomes that are
released into circulation upon fusing of the resultant multi-
vesicular bodies (MVBs) with the plasma membrane (Figure 1).
Importantly, if the Rab GTPases that modulate MVB/plasma
membrane fusion during the release of exosomes are knocked
down, cells still excrete nEVs, suggesting alternative methods of
vesicle formation and release (Ostrowski et al., 2010; Cocucci
and Meldolesi, 2015; Blanc and Vidal, 2017). These may include
ESCRT-independent, ceramide-based mechanisms and direct
budding (so-called ectosomes) (Trajkovic et al., 2008; Cocucci
and Meldolesi, 2015). Exomeres, a new class of circulating
nanoparticle, were recently defined as <50 nm aggregates
composed of lipid, protein, and nucleic acid but without a defined
lipid bilayer, nor reflecting classic lipoprotein composition
(Zhang H, et al., 2018). Larger EVs have also been described,
with one population termed large oncosomes (LOs) found to be
enriched for large fragments of chromosomal DNA, challenging
previously held notions that DNA is trafficked in smaller nEVs
(Vagner et al., 2018). While this review makes the distinction
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of describing nanoscale EVs, also prevalent in blood circulation
are larger microvesicles (MVs) and apoptotic bodies (both of
which bleb directly from the cell membrane) that are often co-
enriched during standard isolation preps (Sódar et al., 2016).
Moreover, lipoprotein particles (LPPs) and ribonucleoproteins
(RNPs) are also relevant traffickers of biomolecules, particularly
extracellular RNAs (Wei et al., 2017), and also contaminate nEV
preps. Methods capable of distinguishing the various nanoscale
vehicles are badly needed (Figure 1).
In general, size is a major driver of nEV heterogeneity, though
it remains difficult to discretely separate vesicles according to
size (Zijlstra and Di Vizio, 2018). Quoted nominal dimensions
for exosomes and related nEV subclasses are numerous, though
trend toward a range of ∼40–150 nm (Coumans et al., 2017),
with MVs/LOs found up to 10µm in diameter (Vagner et al.,
2018). It is recognized that isolation/enrichment methods,
cryopreservation storage (e.g., time, temperature, freeze-thaw
cycling), and analytical approaches all bias measured size range,
morphology, and degree of aggregation (Kusuma et al., 2018).
Contradictory trends for evolution of nEV size distributions at
various storage conditions persist (Jeyaram and Jay, 2018), thus
working with freshly isolated vesicles is preferred when possible.
Some alternatives such as lyophilization or incorporation of
additives to improve stability of banked nEVs have been
introduced (Kusuma et al., 2018).
Numerous distinctive classes of biomolecules make up
nEVs, including lipids, coding and small non-coding nucleic
acids, proteins and biologically active peptides, carbohydrates,
hormones, growth factors, and structural components like
fibronectin and actin (Yáñez-Mo et al., 2015). The extent of
glycosylation of nEVs plays a role in trafficking and function,
in addition to acting as a handle for therapeutic and diagnostic
application (Williams et al., 2018). The cargo and the source of
nEVs often preclude description of their function in the absence
of physiological context, e.g., the stoichiometry of nEV-trafficked
molecules needed to potentiate attributable biological effects is
rarely considered. Instead, typical studies extrapolate function
based on characterizations of the contents of nEVs enriched from
cell culture media. It remains a great challenge to tease out the
complex and likely intertwined autocrine, paracrine, and waste
pathways of nEVs in vivo.
The compositional and temporal heterogeneity of nEVs
enriched from in vitro but especially in vivo sources present
significant challenges (Lacroix et al., 2012; Erdbrügger and
Lannigan, 2016). Consequent irreproducibility of many nEV
studies has led to a swath of attempts at standardization (Witwer
et al., 2013; Coumans et al., 2017; Konoshenko et al., 2018),
optimized isolation methods (Aatonen et al., 2014; Lobb et al.,
2015; Xu et al., 2016), and comparative analyses across isolation
and characterization methods (Rood et al., 2010; Tauro et al.,
2012; Andreu et al., 2016; Rezeli et al., 2016; Ding et al.,
2018). The International Society of Extracellular Vesicles (ISEV)
regularly updates useful position papers establishing guidelines
for the minimum experimental information to categorize nEVs
and how to design effective control experiments for nEV
functional analysis (Lötvall et al., 2014; Witwer et al., 2017; Théry
et al., 2018). Especially relevant is the online knowledgebase
EV-TRACK, developed to centralize data (Consortium et al.,
2017). Notably, much of the work reviewed below is not present
on EV-TRACK, nor meets the minimum guidelines suggested
by experts, on-going issues that raise major concerns regarding
stringency and reproducibility.
Liquid Biopsy of nEVs
There is high diagnostic and prognostic potential for molecular
profiling of aberrantly-expressed biomolecules comprising
circulating nEVs, which are numerous and stable in peripheral
blood and other biofluids (Revenfeld et al., 2014; Jakobsen
et al., 2015; Lai et al., 2017). Diagnostics platforms for profiling
circulating nEVs comprise three steps: (1) isolation/enrichment,
(2) EV sub-fractionation via capture or other manipulation
(e.g., immunoaffinity, microfluidic separation), and (3) analyte
detection/fingerprinting. Isolation and enrichment techniques
vary widely and have been extensively reviewed (Konoshenko
et al., 2018), with differential ultracentrifugation (UC), density
gradient UC, size-exclusion chromatography (SEC), and
commercial PEG-based precipitation kits among the most
commonly applied. It is clear isolation methods must be carefully
considered and ideally varied within a single study (Théry
et al., 2018). Pre-analytical surface immuno-capture using
antibody (Ab) decorated surfaces are widely-used, feasible,
and can be highly-multiplexed (Pugholm et al., 2015). For
nEV detection, many studies quantify number or total average
amount/composition with coarse, imprecise methods such
as western blot (WB) or BCA assay. Nanoparticle tracking
analysis (NTA) and flow cytometry use light scattering to
generate particle counts, which have been correlated with cancer
and disease progression (van der Vlist et al., 2012; Vestad
et al., 2017), but require a large number of particles (>106
per mL). Furthermore, detection based on light scattering is
typically incapable of absolute sizing of nEVs smaller than
∼70 nm, despite TEM evidence that a major fraction of EVs
are smaller (van der Pol et al., 2018; Zhang H, et al., 2018).
Fluorescence triggering, particularly for flow cytometry, has
been applied to reduce the size limitation of light scattering
approaches to ∼40 nm (Arraud et al., 2015; Erdbrügger and
Lannigan, 2016). Yet, fluorescence detection (including for
direct imaging techniques like PALM/STORM) is susceptible to
artifacts like blinking or bleaching, is limited in multiplexing
capability due to broad overlapping fluorophore emission
profiles, and ultimately depends on the effectiveness of
fluorophore labeling, which is known to exhibit artifacts
(Takov et al., 2017; de Rond et al., 2018).
More sensitive analytical biosensors are required for detecting
small or rare events, critical for diagnosing early stage tumor
formation or recurrence. Some promising candidates include
optical resonators (Su, 2015), interferometric imaging (Daaboul
et al., 2016), lens-free holographic microscopy (McLeod et al.,
2015), and electrochemical sensors, often based on enzyme-
linked immunosorbent assay (ELISA) or sandwich-ELISA
(Jakobsen et al., 2015). While these methods have proved
useful for downstream phenotyping of disease-specific nEV
signatures, they are often limited by (1) lack of cost-effectiveness,
(2) requirements for laborious preanalytical isolation and
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FIGURE 1 | Extracellular vesicles (EVs) are a grouping of heterogeneous nanoscale assemblies of (A) various cellular biogenetic origin including but not limited to
MVB-dependent release (exosomes) and direct budding (ectosomes, MVs), (B) exhibiting differential chemical heterogeneity depending on organ or disease specific
context. (C) Lipoprotein particles, ribonucleoproteins, and protein aggregates are often co-enriched with EVs as a result of their overlapping physicochemical
properties, i.e., nominal size and density.
purification, (3) lack of high throughput detection/automation,
(4) requirement for large sample volumes (i.e., low sensitivity),
and/or (5) lack of multiplexibility (i.e., low specificity) (Pugholm
et al., 2015). Many of the approaches reviewed below are focused
on addressing these issues using nanoplasmonic platforms.
NANOPLASMONIC TECHNIQUES
Nanoplasmonics encompasses the study and use of the unique
light-matter interactions at the nanoscale exhibited by metallic
structures, including metal nanoparticles (NPs) and metal
substrates with nanoscale surface roughness (Jackman et al.,
2017). These techniques are increasingly being applied for
liquid biopsy of circulating biomolecules, notably for cancer
diagnostics (Ferhan et al., 2018). From an electromagnetic point
of view, metals can be considered a plasma, characterized by
the free movement of conduction electrons throughout the bulk
material. External electromagnetic fields (i.e., light) impinged on
plasmonic materials can couple with the conduction electrons
oscillating as waves along a metal surface, giving rise to a new
entity with properties of both waves, known as surface plasmon
polaritons (SPPs or just SPs). These are referred to as localized
surface plasmon resonances (LSPRs) when the SP is confined to
a nanoparticle surface with dimensions far below the wavelength
of incident light. Particularly strong electromagnetic fields can be
formed at the interface where two SPs meet, known as a gap-
mode plasmon (Figure 2). With enormous benefit to imaging
and sensing, SPs only occur at quantized frequencies, or modes,
which can be tuned at will via precise control over size and
shape of the material, in addition to its dielectric properties
and those of the surrounding environment (Ringe et al., 2012).
Static measurements of SPs (and their fluctuations in response to
stimulus, analyte binding, etc.) have enabled the use of metallic
substrates or NPs as versatile molecular detectors in many
systems, including DNA hybridization, trace chemical sensing
(Anker et al., 2008), and scanning near-field optical microscopy
(Hermann and Gordon, 2018).
Biosensors based on SPs have many advantages, with potential
for label-free quantitative analysis, a high degree of multiplexing,
and ample potential for miniaturization (Lopez et al., 2016).
These technologies may offer significant insight into nEV
structure, function, and behavior, as (i) their size does not require
ground-breaking sensitivity to observe single binding or sensing
events (Zeng et al., 2019), (ii) most nanoplasmonic setups are
realized as optical imaging platforms that can be easily integrated
with fluorescence microscopy for increased multiplexing or
direct imaging, (iii) the rapid timescale of plasmonic phenomena,
combined with ongoing technical improvements allow for real-
time tracking of nEV motion and interactions, and (iv) labeling-
approaches where nanoplasmonic materials are bound to
targeted EV subpopulations (e.g., via antigen binding) may have
the advantage of subdiffraction imaging, effectively increasing
spatial resolution (Hermann and Gordon, 2018). While the
topic of plasmonic approaches to analyze EVs has already been
reviewed (Im et al., 2015; Shpacovitch and Hergenröder, 2018),
the field is rapidly changing, and this report is more focused on
providing a detailed summary and critical feedback for each of
the studies reviewed.
Surface Plasmon Resonance
Spectroscopy (SPRS)
Surface plasmon resonance (SPR) as an experimentally observed
phenomenon dates back to the late 1960s, based on the
understanding that polarized light is capable of exciting electrons
residing at the interface of a dielectric and conductive metal
surface (Kretschmann and Raether, 1968). Notably, rather than
being an arbitrary event, SP coupling occurs only at well-
defined physical circumstances whereby the wave vector of the
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FIGURE 2 | Depiction of common geometry-dependent plasmon modes for sensing biologicals. Localized surface plasmons (LSPs) originate when interrogating light
interacts with nanoparticles or nanovoids of certain shape. Gray lines pictured represent electric fields. In contrast, on planar sensor surfaces incident light is capable
of provoking pure evanescent modes by way of surface plasmon polaritons (SPPs), propagating waves that exponentially decay away from the interface of dielectric
materials. LSPs exist over a finite frequency range, and they can be directly coupled with propagating light. SPPs occur over a wide frequency range, and they cannot
be directly coupled with propagating light. Gap-mode plasmons typically comprise two metallic nano-features with a nanoscale gap in between. The gap region will
exhibit a confined and intense light spot when the irradiating field is linearly polarized along the vector connecting the particles. Molecules confined in each of the
resulting electric fields can experience a boost in signal detection compared to their native state, with great benefit to biosensing.
incident light and the wave vector of the surface plasmons
are matched, termed the “resonance condition.” The exact
physical description of the resonance condition is derived from
Maxwell’s equations and can be readily calculated over a range
of physical or optical conditions (Hayt and Buck, 2001; Maier,
2007). The key to understanding how one can exploit SP
phenomena to measure analytical signals of biomolecules and
their assemblies is to consider the refractive index (RI) of the
volume where the SPs are travelling. Essentially, the particular
resonance condition for a given plasmonic configuration is
extremely sensitive to changes in RI within a nanometer-sized
characteristic length scale from the material. Via general or target
specific binding of biomolecules or their assemblies (e.g., nEVs),
subtle alterations in RI give way to large observable changes
in resonance condition, which is the essence of the sensitivity,
or gain, for SPR/LSPR techniques. In recent years, there has
been tremendous progress in the synthesis and use of plasmonic
nanostructures that maximize the sensitivity toward biological
reagents (Jans and Huo, 2012; Chinen et al., 2015; Liu et al., 2017;
Zhang Y, et al., 2018).
Physical Background of SPR/LSPR
From an experimental viewpoint, SPR is used to detect events
at the vicinity of the metal surface. In a typical SPR setup
(Kretschmann-configuration) a prism is tightly connected via
a refractive index matching material to a glass sensor chip
coated with a thin (∼50 nm) film of gold, though many other
configurations exist, comprising diffraction gratings, optical
fibers, and optical waveguides (Skivesen et al., 2007; Zhu et al.,
2015; Michel et al., 2017). Interactions between an immobilized
partner (ligand) and unknown sample (analyte) lead to changes
of refractive indices and layer thicknesses within the reach of
an evanescent field at the close proximity of the sensor surface.
This field extends a small distance from the metal surface into
the analyte solution with exponential decay over ∼200–400 nm
from the metal surface in conventional SPR platforms (Ekgasit
et al., 2004).While interaction kinetics occurring very close to the
sensor surface can be measured and quantified very accurately, it
is critical that the binding region between the ligand and analyte
resides within the region of highest evanescent field intensity.
In a reflectance plot, surface reflectance (Ir) is measured as
the incident light angle θ0 is varied. As the incident light angle
reaches the surface plasmon resonance condition, the energy
transfers from photons to surface plasmons, and the resulting
resonance can be observed as a reflectance minimum (Figure 3).
Another common visualization, known as a sensorgram, depicts
the relative shift of the resonance angle as a function of time,
which can produce interaction kinetics between a ligand and
analyte(s) of interest using appropriate mathematical fitting.
The physical principles of LSPR are fundamentally similar
to SPR-based sensing. Instead, while SPR is typically carried
out using planar metal substrates, LSPR relies heavily on the
utilization of metal nanoparticles suspended in solution or
micro- and nano-fabricated metallic structures such as gratings,
nanopillars, and nanoarrays (Willets and Van Duyne, 2007;
Potara et al., 2011; Ho et al., 2012; Ferhan and Kim, 2016).
Figure 4 depicts common configurations for SPR compared
to LSPR.
For LSPR, the photons of excitation light interact with metal
NPs (or metallic structures with nanoscale features) to create
a non-propagating free electron oscillation in the conduction
band of the metal. As discussed in the context of SERS below,
a remarkable electric field enhancement at the close proximity
of the metal nanoparticle/structure can be observed. At the key
plasmon resonance frequency, the absorption and scattering of
light by the metallic nanostructures takes place (Willets and Van
Duyne, 2007). A change to the local dielectric environment close
to the nanostructure alters the polarizability, in turn shifting
the plasmon resonance frequency and the optical extinction
spectrum, an average of absorbed and scattered light collected
by a detector (e.g., CCD or spectrophotometer) (Stewart et al.,
2008). Particular attention is paid to the LSPR peak wavelength,
where the highest light extinction is observed (Ruach-Nir et al.,
2007). Plasmonic NPs can be highly tuned in size and shape to
achieve desired resonance frequencies (Figure 5) (Haes and Van
Duyne, 2004), offering an intriguing window for biosensing and
even allowing naked eye detection (Haes et al., 2004; Chen et al.,
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FIGURE 3 | Typical set-up for an SPR biosensor. Polarized light is directed
through a prism coupled to an interface between a metal (e.g., gold) and
medium in contact with it. For biosensing applications, the sensor chip can be
pre-functionalized with desired capturing ligands (e.g., antibodies) and the
analytes of interest introduced under flow conditions. The reflected photons
shift in angle of minimum intensity (resonance condition) upon changes in
refractive index at the plasmonic surface (e.g., as a result of analyte binding),
to be collected at the detection unit. Two types of graphs can be recorded,
one being the reflected light intensity vs. the resonance angle peak shift (left)
and the other representing the relative change of the resonance angle peak
position vs. time (right). The two cases (i and ii pictured above) represent the
before and after conditions of analyte binding, respectively.
2008). In LSPR, the enhanced electric field distribution is located
at the vicinity of the metal nanostructure, therefore the optimal
sensing distance is∼10–30 nm.
Gold is the most preferred material of choice for LSPR for
several reasons: (i) it is relatively inert, (ii) thiol chemistry
enables straightforward functionalization, and (iii) its plasmon
frequency allows for detection using inexpensive UV-Vis
spectrophotometers (sometimes even an unaided eye) (Sepúlveda
et al., 2009; Hill, 2015; Unser et al., 2015). Other nanoplasmonic
materials, like titanium nitride (TiN), have also been applied for
nEV analysis (Qiu et al., 2019).
Typically, a LSPR biosensing experiment is carried out by
measuring the background, for example blank buffer solution,
and consequently the sample of interest. Prior to detection,
sensing nanostructures are typically functionalized with various
ligands (for instance antibodies, nucleic acid strands, receptors)
to capture the analyte of interest. The non-functionalized
surfaces and sites in the nanostructures are blocked by inactive
components to avoid non-specific adsorption of co-analytes.
Given that the target analyte (e.g., nEVs) typically has higher
RI than the blank background, the local dielectric environment
near the plasmonic nanostructure experiences a change, which
can be seen as the LSPR peak shift toward higher wavelength
(Willets and Van Duyne, 2007; Unser et al., 2015). This
“red shift” corresponds to the concentration of nanostructure-
bound target molecule (or particle), hence enabling quantitative
measurements (Figure 6) (Raschke et al., 2003). However, low
target concentrations remain a challenge, since RI-based sensing
produces relatively small peak shifts, typically<10 nm (Guo et al.,
2010). A secondary probemay be used to amplify such signals, for
instance a gold nanoparticle (AuNP) conjugate (Hall et al., 2011).
As a result, the electromagnetic field becomes more enhanced
and the LSPR peak undergoes a significant broadening along
with an immense shift, of ∼50–100 nm, thus a clear shift e.g.,
from red to blue color, can be perceived (Elghanian et al., 1997;
Chen et al., 2010; Xia et al., 2010). LSPR detection has also been
combined with ELISA for detection of tumor and viral markers at
ultralow concentrations reaching the attomolar level (de la Rica
and Stevens, 2012).
Applications of SPR/LSPR to nEVs
SPR analytical method
Among the first reports of SPR to determine nEV concentration
in solution was carried out via capture of CD63(+)-nEVs
with surface-immobilized antibody (Rupert et al., 2014). The
fundamental finding was to relate the surface-bound mass
increase (via the SPR response) over time to the nEV
concentration in solution. Using nEVs isolated from human
mast cell (HMC-1.2) culture supernatant by UC, the accuracy
of concentration quantification was found to be influenced
by (i) the broad nEV size distribution and (ii) the structural
changes nEVs may undergo upon the binding event to the
antibody-functionalized surface. Control and calibration efforts
with proteins and synthetic lipids were made to address these
issues, and comparison to NTA and bicinchonic acid (BCA)-
based quantification methods was made. Ultimately, when the
size dispersity was considered, the SPR-based concentration
determination yielded ∼2-fold larger concentrations than the
BCA assay indicated. In this regard, the authors assumed
that the nEV preparation was free of contaminating protein
and that nearly every vesicle expressed CD63. The authors
concluded that the measured nEV mass concentration resides
within a reasonable range between 2 and 16µg/mL, derived by
making rather radical assumptions regarding the composition,
buoyant density, and membrane permeability of the nEVs. One
of the foremost biochemical simplifications was that CD63
expression alone sufficiently represents the overall nEV capturing
efficiency of the designed biosensor. The authors followed up
with another study employing an SPR instrument equipped with
two excitation wavelengths (670 and 785 nm) and a scanning
angle feature (Rupert et al., 2016). To estimate the sizes of
surface-bound liposome controls and the bulk concentration of
CD63(+) nEVs, a rigorous mathematical SPR formalism was
introduced for films, spherical nanoparticles, and spherical or
deformed shell structures binding to the sensor surface. This,
in turn, made it possible to achieve better estimates of the
contribution of nEV binding-induced deformation on the bulk
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FIGURE 4 | The most common biosensor configurations. (A) An SPR scheme based on total internal reflection (TIR) and the typical prism-coupling (Kretschmann
configuration) which is needed for transverse magnetic (TM) modes of surface plasmon polariton excitation. (B) An LSPR extinction, TIR, and dark field measurement
schemes for nanoarray surfaces, respectively. Figure reproduced as is from Lopez et al. (2016) under BY-NC-ND 3.0.
concentration determination. The key finding was that a dual-
wavelength SPR system allowed for determining thicknesses of
bio-films comprised of nanoscale particles. The sources of error
of the nEV bulk concentration overestimations made in the
previous study were successfully traced to mainly stem from
the binding-induced deformation. However, it is to be noted
that the introduced methodology probed only the subpopulation
of CD63(+) nEVs, corresponding to ∼5–10% of the entire
EV sample. Another shortcoming of this pioneering work was
that a direct comparison between the NTA (particles/mL) and
total protein content (µg/mL) is clumsy. Firstly, converting the
number of particles per volume (NTA) to mass per volume is
affected by a plethora of uncertainties and second, NTA and BCA
measurement are each sensitive to the impurities present, e.g.,
soluble protein aggregates, yet to greatly varying degrees.
Recently, a robust, real time, label-free SPR biomarker
detection platform for ICAM-1(+) nEVs was developed for
predicting the existence and stage of coronary heart disease
(CHD) (Hosseinkhani et al., 2017). UC, SEC, and commercial
precipitation kits (ExoQuick-TCTM) were tested for EV isolation
from cell culture supernatants. The optimized SPR detection
platform employed surface-immobilized antibodies: anti-ICAM-
1, anti-CD63, and anti-IgG1, which could distinguish ICAM-
1(+) nEVs released under simulated inflammatory stress.
With the motivation of avoiding tedious sample purification
and labeling steps, as well as accomplishing a robust and
sensitive detection of nEV subpopulations, the described SPR
methodology was successfully employed using low sample
volume consumption and without the need for (external or
internal) calibration. Unfortunately, neither the limit of detection
(LOD) nor limit of quantification (LOQ) were assessed. Also,
a concern can be raised in terms of pinpointing ICAM-1
expression as an adequate biomarker for CVD prognosis and
diagnosis. These slight defects, however, do not take away from
the appealing findings of using SPR for the purposes of EV-based
biomarker detection.
Another study focusing on both cell line-derived and human
blood-isolated nEV detection by SPR was carried out (Grasso
et al., 2015). There the authors employed three divergent
breast cancer cell lines, MCF-7, BT-474, and MDA-MB-231,
to generate nEVs, isolated by a combination of low-speed
centrifugation, ultrafiltration (UF), and further purification by
SEC. Plasma nEVs followed the same protocol excluding UF
steps. A multiplexed SPR assay approach with two typical
exosomal (CD9 and CD63) and four cancer-specific (CD24,
CD44, EpCAM, and HER2) biomarkers was demonstrated, with
a prerequisite of sample volume in the range of 5–20µL. In order
to prevent non-specific binding, a self-assembled monolayer of
carboxylated polyethylene glycol (PEG) polymer was first added
to the gold surface, followed by neutravidin treatment and the
biotinylated antibodies. Large variations in biomarker expression
was observed across nEVs isolated from the three breast cancer
lines, notably with modest CD9 and CD63 expression, abundant
CD24 and CD44 expression, practically negligible EpCAM, and
moderate HER2 expression levels. Despite commendable insights
and findings, the research had a few caveats that experts in the EV
field may want to take into consideration to improve upon this
approach in future studies. Namely, (i) adequate controls e. g., in
the form of non-cancerous nEVs, were lacking, (ii) rigorous and
clear statistical treatment of the obtained results was insufficient,
(iii) description of the SPR signal processing mathematics was
ambiguous, (iv) only qualitative color-coded panel(s) of the main
results were shown, (v) data were inconclusive with respect to
the plasma-originating nEV profiling by SPR, (vi) little attention
was paid to assay reproducibility, and (vii) LOD and LOQ
were absent.
Taking advantage of the previously mentioned benefits of
SPR, and expanding on the concept, an SPR imaging (SPRi)
platform usingmultiplexed antibodymicroarrays was introduced
(Zhu et al., 2014). The intention was to quantify EVs in tumor
cell culture medium directly. Four different cell lines were
analyzed: MHCC97H (human hepatocellular carcinoma, highly
metastatic), MHCC97H (human hepatocellular carcinoma,
meagerly metastatic), B16-F1 (melanoma, highly metastatic),
and B16-F10 (melanoma, meagerly metastatic). EVs were either
isolated by UC, or were measured in the supernatant directly.
The SPR system comprised a light source irradiating the gold
sensor surface through a coupling prism at a fixed angle position
and a CCD camera for detecting the reflection and imaging the
surface (Figure 7). Since the pixels on a CCD detector array are
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FIGURE 5 | LSPR naked eye detection and extinction spectra for various Ag
and Au NP solutions. A concrete representation of an LSPR measurement
carried out for different sized and shaped metal NPs. (A) The transmission
electron micrographs (1–6), corresponding metal NP solutions (from red to
blue), and measured UV-Vis extinction spectra for their solutions. (B) The
solutions’ and spectrums’ color schemes are paired. By modifying the
physicochemical attributes of metal NPs, their respective LSPR conditions can
be tuned to line up with desired technical settings (e.g., the selection of laser
wavelengths) to achieve the best possible sensitivity and selectivity for a given
assay. Reprinted by permission from Springer Nature (Haes and Van Duyne,
2004)© 2004.
sampled concurrently, the reflected light intensity at each pixel
can be easily monitored (Campbell and Kim, 2007). Therefore,
the amount of surface-bound analyte at each spatial position can
be accurately studied in a high-throughput manner. In essence,
Zhu et al. harnessed these capabilities by printing microarrays
of antibodies specific to transmembrane proteins of nEVs. The
total palette of antibodies included ones against CD9, CD63,
CD41b, CD81, CD82, E-cadherin, and EpCAM. A few anti-
intracellular part antibodies were chosen to demonstrate the
biogenesis pathway of nEVs: CD9 N-term, CD81 C-term, CD82
C-term, and E-cadherin C-term. Control antibodies used were
against IgG, MET, in addition to HRP-conjugated secondary
antibodies. The nEVs isolated from MHCC97H cell culture
supernatant bound to all the expected antibodies, while negligible
signal stemmed from negative control anti-IgG. Anti-CD9 and
FIGURE 6 | Principle and schematic representation of a biosensor based on
light scattering from a single AuNP. (A) Single AuNPs are functionalized with
biotinylated BSA protein which subsequently binds streptavidin. (B) Mie theory
calculations for the three different environments shown in (A). (C) Left: true
color photograph of a sample of functionalized AuNPs in dark- field
illumination. Right: experimental setup facilitating dark-field microscopy of
single AuNPs immersed in liquids. Reprinted with permission from Raschke
et al. (2003). Copyright (2003) American Chemical Society.
anti-CD41b demonstrated especially high binding capability,
indicating the expression of corresponding membrane proteins
on the investigated nEVs (and verified by WB). Measurements
directly on unprocessed culture supernatant provided similar
binding results with consistently high signals, suggesting that
it could be directly used for nEV binding and transmembrane
structure identification studies. Lastly, the changes in amounts
of nEVs derived from MHCC97H cell culture supernatant were
investigated. Secretion of nEVs was modified using siRNA-
Rab27a transfection (hypothetically decreasing exosome-type
secretion) and monensin treatment (hypothetically increasing
secretion). When monitored by the SPRi microarray sensor
chips, the binding signals to anti-CD9 and anti-CD41b
were significantly higher in the non-siRNA transfected and
monensin-treated groups, confirming the hypotheses.
With respect to the immense experimental and
standardization efforts made in the EV field to resolve the
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FIGURE 7 | Principles of the SPR imaging (SPRi) system. The core of the flow cell is a functionalized Au biosensor comprising printed antibody regions whereby the
capturing and detection of nEVs takes place. Prism coupling is used to excite the SPR, and the reflected light is collected by a CCD detector. Upon nEV binding, the
local refractive index at the vicinity of the sensor surface increases. This detunes the resonant coupling of light to surface plasmon polaritons, and at the resonance
condition, the resonance angle peak minimum is observed in the intensity of the reflected light. Consequently, the peak shift from before and after the affinity binding
can be quantified to determine the interaction kinetics and surface-bound mass. Reprinted with permission reproduced from Zhu et al. (2014).
most efficient methods for isolation and to assess the purity, the
work by Zhu et al. represents a decidedly large leap forward,
having deduced that the SPRi signals indeed originate from EV
binding rather than free protein or membrane debris in the cell
culture supernatant (Zhu et al., 2014). Although well-justified,
a concern can still be raised, whether the high signals stem
from non-exosomal debris in the supernatant. Several validation
experiments would have been needed to strengthen the made
observations. For instance, a useful control would have been EV
purification by the density gradient method and comparison
of signals between the “debris” fractions and “EV” fractions.
Moreover, the EV characterization in general was short of size
distribution data (NTA or DLS) or high quality TEM images.
Recent attempts have begun to appreciate the complexity of
more clinically relevant nEV preps using label-free plasmonic
approaches. A custom-made SPR instrument was used to detect
nEV subpopulations amongst a heterogeneous sample isolated
from patient serum (Sina et al., 2016). A sandwich approach
on a gold surface was utilized; either biotinylated anti-CD9 or
anti-CD63 was immobilized on streptavidin-coated surface to
capture vesicles. Anti-HER2 was utilized as a detection antibody
to identify breast cancer nEVs were isolated from cell culture
medium using the commercial precipitation Total Exosome
Isolation Reagent (TEIR). In the assay development phase, 10%
HER2(+) nEVs could be detected when predetermined portions
of HER2(+) BT474 and HER2(–) MDA-MB-231 cell-derived
nEVs were used. A calibration curve based on the theoretical
minimum and maximum sensitivities was calculated via titration
of heterogeneous mixtures of the two aforementioned nEV types.
The LOD was defined at 2,070 nEVs/µL. The authors further
isolated nEVs from six HER2(+), two HER2(–) breast cancer
patient serum samples, and two serum samples from healthy
individuals. Bulk nEV capture onto the biosensor surface was
independent of the capturing agent used (either anti-CD9 or
anti-CD63) and the signal levels in the capturing phase were
rather similar. Upon detection using anti-HER2, 14–35% of the
bulk nEV population consisted of HER2(+) nEVs for the breast
cancer patients. While the study did not have any obvious flaws,
it would have benefited from slightly broader perspective, e.g.,
nEVs from other cancerous and non-cancerous cell lines or
larger cohort of patients could be tested—which the authors also
suggested themselves.
An intriguing concept combining LSPR and SPR was recently
introduced (Di Noto et al., 2016). Monoclonal gammopathy
of undetermined significance (MGUS) has been observed as a
significant intermediate step in all cases of multiple myeloma
(MM) and the role of nEVs in this step, as well as in the
development of MM in general, has drawn interest. nEVs
from 5 MGUS, 10MM, and 10 healthy individuals were
isolated by UC and further purified by sucrose gradient UC.
The authors had previously perceived that heparan sulfate
proteoglycans (HSPGs) on the cell surface are mediators
in the nEV uptake by the target cells (Di Noto et al.,
2014), where MM-derived nEVs were internalized more
than nEVs isolated from MGUS and healthy individuals.
Therefore, in order to differentiate these three nEV groups
and to quantify their corresponding binding efficiencies,
the researchers developed an SPR biosensor functionalized
with heparin (a structural analog of heparan sulfates). As
equivalent concentrations of nEVs were passed over the heparin-
functionalized SPR biosensor, the binding of MM-isolated
nEVs was consistently higher than in the two other groups.
Thus, the SPR platform was shown to be a robust and label-
free method to tease out differences between nEVs. Another
incremental advancement to SPR was recently introduced
using magnetic NP-enhanced nEV detection for grating-coupled
SPR (Reiner et al., 2018). The system allowed for parallel
SPR and plasmonically-enhanced fluorescence monitoring of
MSC-derived nEVs, representing a novel usage of label-enhanced
SPR and fluorescence in combination.
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In conclusion, the innate features of SPR offer a range
of opportunities for nanoscale detection and characterization
of nEVs—typically by label-free manner. High tunability of
Au-based sensors provide room for creativity in method
development. The current setbacks that hamper bridging the
gap between research and clinical applications mostly relate
to the perceived complexity of SPR techniques, and rather
bulky instrumentation. In terms of nEVs in particular, non-
exosomal debris (lipoproteins, aggregated proteins, etc.) in
samples exacerbate reaching adequate specificity and sensitivity
as all these components may bind to biosensor surface and
change the local RI at its vicinity. Advancements in optics
(lasers, optical components, miniaturization capabilities) could
be harnessed to address the instrument-related shortcomings. On
the other hand, rapidly developing understanding of chemical
modification of plasmonically-active materials may provide new
insights for high-precision biosensor surface preparation (Jans
and Huo, 2012). Another useful angle for the future of SPR work
would be the adoption of an EV-mimicking standard for use as a
control to model binding.
LSPR-based sensing
Generally, LSPR platforms consist of detecting analytes located
near (i) metallic nanostructure arrays on a solid support
generated using micro- and nano-fabrication lithographic
techniques or (ii) nanoparticles, freely suspended in solution or
deposited onto a solid support.
Nanohole and nanopillar arrays. The nano-plasmonic exosome
(nPLEX) is an LSPR-based assay utilizing optical transmission
FIGURE 8 | Label-free detection of nEVs using the nPLEX biosensor. (A) The well-defined biogenesis route of exosomes from cancer cells via multivesicular body
(MVB) formation, consequent fusion with the cell membrane, and excretion of exosomes. The upper inset displays membrane proteins on the shell of the exosome;
these proteins act as common recognition sites in biosensing applications. The lower inset shows a transmission electron micrograph of exosomes isolated from
human ovarian cancer cell (CaOV3) culture. (B) Near a periodic nanohole surface the electromagnetic fields are clearly enhanced and accumulated as shown by
finite-difference time-domain (FDTD) simulation. The enhanced field spreads over the nanostructure from one hole to another, which enables high sensitivity for the
nPLEX assay. (C) The nPLEX sensor imaged by a scanning electron microscope (SEM). The nanoholes of diameter 200 nm are distributed evenly over the surface with
periodicity of 450 nm (the inset demonstrates a closer view of the surface). (D) The nPLEX system is equipped with a metal-oxide-semiconductor (CMOS) detection
unit for acquiring transmitted light intensity from the sensor chip. (E) The binding of nEVs to a periodic nanohole structure induces a change in the local refractive index
and thus a spectral shift in transmission spectral peak. Wavelength shifts, or intensity changes at fixed wavelength, are monitored for nEV quantification. (F) An SEM
image demonstrating surface-adsorbed exosomes on the nPLEX sensor. Reproduced by permission from Springer Nature (Im et al., 2014).
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through an array of periodic nanoholes patterned to a 200 nm
thick gold film on a glass substrate (Figure 8) (Im et al., 2014).
Sensitive high-throughput nEV analysis was accomplished by
using nanohole dimensions approximating average nEV size.
Detection was based on either spectral shifts or intensity changes
that were induced by nEV binding to antibody-functionalized
nanoholes. To control non-specific binding, nPLEX devices
were pre-coated with a mixture of short- and long-chained
PEG polymers. First, nPLEX assay protocol was established
through examination and quantification of nEVs secreted by
in vitro CaOV3 OvCa cells. A high-affinity binding constant
of ∼36 pM and LOD of ∼3,000 exosomes (670 aM) was
observed when the nanoholes were functionalized with anti-
CD63, and subsequent capturing of CaOV3-derived nEVs was
performed. In comparison to WB and ELISA, the nPLEX protein
quantification performed better (sensitivities 104 and 102-fold
higher, respectively). Notably, secondary labeling significantly
amplified signaling of the nPLEX platform: spherical Au
nanoparticles showed a 20% increase and larger, star-shaped
Au NPs showed 300% amplification. Another OvCa cell line,
OV90, was used in parallel with CaOV3 to compare the
capabilities and correlation of nPLEX against ELISA (EpCAM,
CD24, CA125, MUC18, EGFR, and HER2 were used as protein
markers). Correlation of R2 > 98% was found. Concurrently,
the captured nEVs were eluted from the nanostructures, and
a quantitative real-time PCR (qRT)-PCR was implemented to
investigate the mRNA contents of the nEVs. Next, the researchers
did a molecular screening of nEVs encompassing various non-
cancerous and cancerous cell lines. Subsequent observations
were applied to a cohort of OvCa (n = 20) and cirrhosis
(non-cancerous, n = 10) patients to determine the nPLEX
performance. nEVs were enriched only using 0.2µm membrane
filtration. The amounts of EpCAM and CD24 were significantly
higher in the OvCa group. Lastly, a small cohort (n = 8)
of OvCa patients undergoing chemotherapy were profiled to
evaluate patients’ response to treatment. Levels of EpCAM and
CD24 showed a decreasing trend in the corresponding patients.
In future, the use of larger patient cohorts and additional
disease models will strengthen the power and applicability of
the platform.
In a similar study, nanohole-based surface plasmon resonance
platform named intravesicular nanoplasmonic system (iNPS)
was developed to screen both surface as well as intravesicular
proteins trafficked by nEVs released from ovarian cells (Park
et al., 2017b). The engineered substrates provided a sensitivity
capable to detect nEVs in as little as 0.5 µL sample per
marker in a high-throughput manner using a 10 × 10 array.
Another nanohole array assay was used for detection of
pancreatic ductal adenocarcinoma (PDAC) (Yang et al., 2017).
The sensing scheme was based on measuring the resonant light
transmission—more specifically quantifying the spectral shifts—
upon binding of tumor-derived nEVs to a periodic array of
antibody-functionalized nanoholes. A 100 nm thick Au layer with
nanoholes of 200 nm in diameter and periodicity of 500 nm
was constructed. Platform calibration and validation was via a
PDAC nEV panel on a training cohort of 32 patients and healthy
controls. As a result, a five-marker PDACEV signature comprising
EGFR, EpCAM, MUC1, GPC1, and WNT2 components was
established (accuracy reaching 100%) and further validated with a
cohort of 43 human samples, with an accuracy of 84%, sensitivity
of 86%, and specificity of 81%. A correlation study was performed
between the PDACEV signature and gold standard markers
(CA19-19 and CEA), finding none. Sixty-one percent of PDAC
patients showed elevated CA19-19 levels and 17% of PDAC
patients showed elevated CEA levels, while PDACEV values
revealed 89% of PDAC patients. High specificity and sensitivity,
scalability, throughput, automated operation, molecular printing
capabilities, cost effectiveness, and low sample consumption were
the advantages of the developed method. Meticulous statistical
analyses complemented the different phases of the study and
underlined the high translation potential of the platform.
Two-dimensional (2D), quasi-three-dimensional (quasi-3D),
and 3D plasmonic photonic crystal (3D PPC) nanostructures
have been developed and evaluated for nEV detection (Zhu et al.,
2018). For 2D gold nanoholes, SPs were found to localize at
the edges of the nanoholes. Asymmetrical Au nanoholes showed
a higher electromagnetic field intensity and therefore higher
sensitivity. Quasi-3D Au nanoholes consisting of Au nanoholes
on top and Au nanodots at the bottom produced an even greater
EM field intensity due to the hybrid coupling of LSPR and
Fabry-Perot modes. The 3D PPC nanostructure was created by
adding an additional array of Au nanosquares to the top of
the quasi-3D nanoholes. This served to further strengthen the
EM field and increase sensitivity. Target nEVs were enriched
by UC from fibroblast L cell lines for detection using the 3D
PPC platform, first coated with anti-EpCAM antibody for nEV
capture. Detection range was measured to be between 104 and
1011 particles/mL. While the study had its impressive merits
from the nanomaterials development and physics point of views,
there are some notable oversights. First, nEV concentration was
measured only by NTA, and subsequently used as an absolute
value for sensitivity assessments. The authors did not report
complementary nEV quantifications (e.g., WB or TEM), nor
assess purity of the preps. A concern can be raised, whether the
speculated intravesicular filaments pictured in the final image of
the study are due to non-nEV impurities, thus resulting in the
larger plasmon sensing area, which was considered to contribute
to the higher sensitivity of the 3D PCC nanostructures. A second
suggestion would be to measure several additional sources/types
of nEVs for validation.
Single nEV detection was pursued by a LSPR imaging (LSPRi)
system (Raghu et al., 2018). The sensing elements have Au caps
topping a matrix of quartz nanopillars, the latter being relatively
inert to non-specific binding. The individual nanopillars (total
height 497 nm with diameter ∼90 nm) were assembled together
into an evenly spaced 10 × 10 or 20 × 20 array chip for high
multiplexity (Figure 9). A CMOS camera was capable of imaging
6,400 nanopillars (16 arrays with 400 nanopillars each) with
a resolution of 0.36 µm2 per nanopillar, while spectra were
simultaneously acquired with a CCD-based spectrophotometer.
nEVs were isolated from MCF7 breast adenocarcinoma cells by
commercial precipitation kits. Roughly 1 × 105 nEVs/mL (by
NTA) were introduced to the LSPRi sensors using a microfluidic
system. The authors state that single-nEV binding events are
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FIGURE 9 | Nanoplasmonic pillars. (A) 25.4mm diameter LSPRi sensor chip. (B) LSPRi image of a 20 × 20 array, pitch size of 600 nm, scale bar: 1µm. (C) LSPRi
image of sixteen arrays in the field-of-view taken using 100X/1.4 NA objective, each consisting of 400 plasmonic nanopillars in a 20 × 20 square lattice and 500 nm
pitch, scale bar: 10µm. (D) False colored SEM image of a 10 × 10 nanopillar array, scale bar: 1µm. (E) High-magnification false colored SEM image showing detailed
view of individual nanopillars, scale bar: 200 nm. (F) Diagram illustrating size matching of individual nanopillars diameter (d = 90 nm) to that of nEVs (∼50 nm < d <
200 nm), allowing digitized vesicle detection while also elevating the sensor to minimize background contributions from the substrate. Figure reproduced under
Creative Commons License 1.0 from Raghu et al. (2018).
resolvable from free protein as a result of the subsequent discrete
step function response in comparison with a smoother integrated
response that smaller analytes would produce. For this work,
it is noted that precipitation kits may induce artifacts to the
observed signals in the form of aggregated nEVs or larger non-EV
contaminants due to the isolation reagent.
Other planar geometries. A technique termed interferometric
plasmonic microscopy (iPM) was recently introduced (Yang et al.,
2018). The iPM sensors were glass cover slips coated with 2 nm
Cr and 47 nm Au slabs. A CMOS camera and 637 nm laser
were the central pieces of the optical setup (Figure 10). The
compelling novelty was the common-path interferometry that
harnesses the reflected light and scattering signal from objects
within the reach of the evanescent field (∼200 nm above the
surface). The calibration of the system was carried out using
silica nanoparticles. In-house image processing algorithms were
employed to reconstitute the interaction events of A549 lung
cancer cell line-derived nEVs. Different interaction scenarios
were investigated, starting with nEVs and charged Au surfaces.
As expected, adsorption of nEVs was dependent on the surface
charge of the Au surface, e.g., only Au surfaces modified with
HS-PEG-NH2 (positively charged surface) bound the anionic
nEVs. When integrated with fluorescent microscopy and the
nEV lipid membrane was labeled with DiIC18, fluorescence
signals correlated well spatially with the iPM image analyses.
Through the iPM analysis, nEVs demonstrated a continuous
distribution between 30 and 150 nm with a peak value of
∼62 nm. Notably, the NTA analyses showed higher values at
∼120 nm. Although rigorous biophysical work was represented,
the known EV/liposome shape reformation upon binding onto
the Au surface was not addressed—which may contribute to the
observed results.
A similar nano-groove based sensor referred to as a
plasmonic interferometer array (PIA) was invented for real-time
detection of circulating nEV proteins with high sensitivity and
portability (Zeng et al., 2019). The PIA biosensor measures
intensity modulation at a single wavelength created by SP waves
upon sensor illumination at the normal direction to artificial
nano-grooves (Figure 11). SPs traveling along the radial direction
of the rings interfere with light directly transmitted through a
small aperture at the center of the grooves. Transmitted light
intensity from each sensor is dependent on the change in RI
between the opening and groove rings. To test feasibility of
the PIA sensors, an 8 × 8 chessboard array was designed
with two different radii (R1 = 4.25µm and R2 = 4.5µm).
By increasing the RI, transmitted signal of R1 increases while
R2 decreases, allowing for coupling of horizontally adjacent
neighbors. The signal change was added by subtracting the
decreasing R2 signal to the increasing R1 signal, which
greatly reduced background noise and increased signal-to-noise
ratio (SNR). To demonstrate the potential for early cancer
diagnosis, EGFR (epidermal growth factor receptor) was used
as a marker for A549 lung cancer cells. Following binding
of anti-EGFR antibodies to the PIA biochip, high detection
sensitivity was observed, with a SNR of 51.76, corresponding to
a resolution of 3.86 × 108 nEVs/mL. The PIA biochip was also
integrated onto a smartphone-based camera microscope system,
exhibiting SNR of 8.23 corresponding to a sensing resolution of
9.72× 109 nEVs/mL.
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FIGURE 10 | The interferometric plasmonic microscopy (iPM) system for
physical (size) and biochemical (interaction) characterization of nEVs. (A)
Schematic of the iPM. (B) Outline of the interferometric scattering model. (C)
Image of 100 nm silica nanoparticle without (scale bar: 3µm) and (D) with
(scale bar: 300 nm) image reconstruction. (E) k-space image of C after
2D-FFT. (F) Longitudinal intensity profile across the silica particle in C (cyanine)
and D (red). (G) Signal-to-noise profile in iPM detection of 100 nm silica
particles using the running-average algorithm and the theoretical shot-noise
limitation (dashed trace). Figure reproduced from Yang et al. (2018)© 2018.
Self-assembled monolayer coated gold nanoislands (SAM-
AuNIs) have been recently introduced as sensitive and
inexpensive optochemical biosensors, produced by a two-
step deposition-annealing procedure (Thakur et al., 2017).
The authors included both nEVs and also larger MVs, isolated
from four different sources (two in vitro cell lines, serum, and
urine). Without surface functionalization, reported LOD of
0.194µg/mL and linear dynamic range of 0.194–100µg/mL
were obtained. However, a concern is raised regarding isolation
methods, which varied for each type of sample; cell culture
supernatants employed UC and filtration, while serum and
urine EVs were isolated using different commercial isolation
reagents. The vaguely described MV isolation method stands
out since the study essentially focuses on investigating nEVs vs.
MVs, and the outcomes likely depend heavily on the chosen
MV enrichment procedure. Also, given that each method likely
yielded varying levels of purity, which were not directly assessed,
non-EV originating contaminant proteins cannot be excluded
and concentration estimates based on protein content may not
be accurate. A critical suggestion would be to use a uniform
isolation panel for all the different preparations and a consequent
endeavor to qualitatively or quantitatively determine the purity
of the preparations [further suggestions can be found e.g., in
references: (Webber and Clayton, 2013; Maiolo et al., 2015)].
Another more recent LSPR sensor using AuNIs was reported,
decorated with the peptide Venceremin (Vn96), which exhibits
strong affinity to nEV surface heat-shock proteins (HSPs)
overexpressed on many tumor cells (Bathini et al., 2018).
Enthusiasm was limited by the heterogeneity of the AuNIs
(20–80 nm), lack of clinical samples tested, and no assessment
of statistical relevance (sensitivity, specificity, etc.). Joshi et al.
introduced a very sensitive label-free LSPR biosensor to
detect microRNA-10b (miR-10b) levels in biological fluids and
lysed nEVs (Joshi et al., 2015). Single nucleotide specificity
and attomolar (10−18 M) sensitivity was reported. Pancreatic
cancer cells (PPCs) are characteristic to pancreatic ductal
adenocarcinoma (PDAC), and PCCs are known to overexpress
miR-10b in PDAC. The aim was to study whether PCCs
release miR-10b into the cell culture medium or circulation,
and to explore whether the miR-10b levels in nEVs could
differentiate between chronic pancreatitis (CP), and individuals
with and without PDAC pathology. Gold nanoprisms were
synthesized, attached onto a glass substrate, and functionalized
with complementary oligonucleotides. The developed LSPR
sensor was demonstrated to work with PCCs (AsPC-1, BxPC-3,
and PANC-1)-derived conditioned media and nEVs. Successful
differentiation was also performed between PDAC or CP
patients and normal controls in plasma, nEVs, and post-UC
supernatants. The authors pinpoint various structural attributes
in the LSPR sensors that enable high sensitivity, in particular
the charge transport of the gold nanoprisms through the
DNA backbone upon forming duplexes with the ssDNA. The
regeneration capability and stability of the LSPR biosensors was
also tested, and the authors concluded that the sensitivity remains
unchanged at least over 5 days.
Plasmonic nanoprobes. A colorimetric nanoplasmonic LSPR
assay has been introduced (Maiolo et al., 2015). In brief, when
cationic AuNPs are titrated into contaminant-free nEVs, NPs
cluster at the EV membrane to generate a LSPR red-shift that
is proportional to the nEV concentration in the sample. If non-
nEV soluble protein is present, the AuNPs are swarmed by a
protein corona, preventing interplay with nEVs and no LSPR
shift is present. Using this method, protein contaminants could
be detected with LOD as low as 5 ng/µL. Notably, this method
was also recently exploited in another study (Busatto et al., 2018)
and may serve as a useful and rapid method to detect free protein
contamination for general nEV characterization.
The nano-plasmon enhanced scattering (nPES) assay was
developed and tested for pancreatic cancer as a model approach
(Liang et al., 2017). A silica sensor chip comprising anti-CD81
functionalized wells was used to capture tumor-derived nEVs.
The finding of the study was the concept of utilizing two
types of plasmonically active Au nanoparticles, Au nanoparticles
(AuNPs) and rods (AuNRs), to recognize tumor-derived nEVs.
In the platform development phase, the authors noted that anti-
CD63-AuNP and anti-CD9-AuNR nanoparticles formed AuNP-
nEV-AuNR complexes on the sensor surface, and a significant
spectral shift and intensity of the scattered light was observed
(Figure 12). The nPES assay’s performance was characterized by
known nEV plasma concentrations, and nPES area ratios (area
of nPES signal vs. well area) were used to evaluate unknown
sample EV concentrations. The nPES assay outperformed ELISA
in regard to sample consumption (1 µL vs. 150 µL), analysis
time (5 h vs. > 24 h), sensitivity (0.2 vs. 77 ng/µL), and cost.
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FIGURE 11 | Plasmonic interferometer array (PIA) biochip. (a) Schematic of a ring-hole PIA and (b) cross-section view. (c) SEM image of a 5 × 5 array of plasmonic
interferometer with increasing R from left to right, bottom to top. (d) Transmitted light can be imaged on a CCD camera. (e) Schematic diagram of the experimental
setup. (f) Transmission of each interferometer was modulated sinusoidally by R, showing different sensitivity when glycerol-water solutions of increased concentrations
were flowed on the sensor surface. Black arrows indicate the interferometers with highest sensitivities. Reprinted, with permission, from
(Zeng et al., 2019) © [2017] IEEE.
After a meticulous proteomics and bioinformatics screening,
the anti-CD63-AuNP probe was replaced with EphA2 (anti-
EphA2-AuNP) as a pancreatic-cancer-specific EV marker. Cell
line supernatants from normal (HPNE) and tumor (PANC-1)
tissue at progressive tissue culture time points were analyzed
to evaluate the specificity of the nPES platform. The PANC-1
EphA2EV signals were significantly higher at all time points. As
plasma samples from normal healthy controls (NC), pancreatitis,
and pancreatic cancer patients were tested, the EphA2-EV signals
were significantly higher. The same trend was perceived when
a mouse xenograft model was used by injecting athymic nude
mice with PANC-1 cells and analyzed for EphA2 blood levels
every 10 days after the injection. The EphA2-EV levels also
correlated with the tumor size. At the final part of the study
the EphA2-EV nPES assay was harnessed to analyze a cohort of
normal control individuals (n = 48), chronic pancreatitis (n =
48), and pancreatic cancer patients (n = 49) at different stages
of the disease. The non-diagnostic biomarker CA19-9 (which
is typically used to monitor the patient responses to therapy)
was used for benchmarking the clinical performance of the
EphA2-EV nPES levels. As 23 pancreatic cancer patients were
evaluated pre and post neoadjuvant therapy, the EphA2-EV levels
in comparison to CA19-9more accurately reflected the treatment
status for patients with good or partial therapy responses.
The study was well outlined, and the results supported by
additional experiments (SEM, WB) as well as carefully designed
statistical analyses. As noted by the authors, the specificity
and generalizability of the nPES platform could be improved
further by replacing the secondary anti-CD9-AuNR probe with
additional cancer-specific probes.
To summarize, LSPR techniques complement SPR methods
well, and they can be used as stand-alone applications
for nEVs. The needed instrumentation is relatively cost-
effective and operator-friendly, simultaneously showing potential
for miniaturization, automation and integration with e.g.,
microfluidics. A good example is the work byMaiolo et al. (2015),
where the authors used a colorimetric LSPR assay able to infer
the purity of nEV preparations by naked eye. However, cavities
similar with SPR techniques can be found in the LSPR based nEV
detection and characterization. While LSPR methods introduce
compelling fundamental physics and theoretical viewpoints, the
biological relevance with respect to specificity, sensitivity, and
statistical power are often in need of addressing. Especially
crude and complex sample matrices such as human plasma
without any pre-treatment pose common issues. Many of these
can be overcome e.g., meticulous experimental design, in-
house technical innovations, biophysical modeling, and rigorous
statistical calculations. Finally, LSPR particle heterogeneity is
rarely accounted for, but certainly influences measurement to
varying degrees, and should be reported.
Surface Enhanced Raman
Spectroscopy (SERS)
Physical Background of SERS
In Raman spectroscopy, laser light is used to irradiate a
sample of interest and the resultant inelastically scattered
photons are collected by a detector. The energies of such
photons precisely correspond to the chemical bonds and
structures present in the sample. Hence, a Raman spectrum
consists of wavenumbers (inverse centimeters, cm−1) on the
abscissa and scattering intensities on the ordinate. Raman
spectroscopy affords high chemical specificity, minimal to
no sample processing, is inherently non-destructive, and
relatively inert to aqueous background. The main disadvantages
for spontaneous Raman spectroscopy are weak signal and
high fluorescent/photoluminescent backgrounds, particularly for
biological specimens. However, these shortcomings can be
efficiently overcome using SERS. Notably, even single molecule
sensitivity can be achieved (Otto, 2002) as well as enhancement
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FIGURE 12 | Design of an nPES platform for nEV detection. (A) Schematic overview of the nPES assay for specific detection of EVs. (B–D) Dark-field microscope
(DFM) images of AuS-anti-CD63 (green), AuR-anti-CD9 (red) and AuS-EV-AuR complexes, which are detectable as bright yellow dots. Scale bars: main images, 2µm;
magnified images, 100 nm. (E,F) Scattering spectra (E) and intensities of AuS-anti-CD63 (ref. 48), AuR-anti-CD9, and AuS-EV-AuR complexes (F). The scattering
spectra and related intensities were recorded from 10 randomly selected particles for each complex by a spectrograph CCD equipped with a monochromator
(CASCADE 512B, Roper Scientific). Data represent mean ± SEM; n = 10 replicates per sample. Reprinted by permission from Springer Nature
(Liang et al., 2017) © 2017.
factors beyond ∼1015. SERS is an inherently plasmonics-
based technique, describing the exploitation of the coupling
of photons to charge density oscillations (i.e., plasmons) of
the conductive electrons in metals. Thus, in SERS, the high
chemical specificity of Raman spectroscopy is combined with
unprecedented sensitivity accomplished by plasmon-assisted
scattering of molecules on or near (typically within ∼10 nm)
metal nanostructures. The formation of “hot spots”—where
the highest signal enhancement is observed—is an important
physical phenomenon, occurring where two or more SERS-
active regions come into spatial contact, i.e., gap-mode plasmons
(Figure 2). SERS is a powerful and sensitive modern analytical
technology that has been successfully applied to medically-
relevant detection of biomolecules like metabolites, nucleic
acids, and proteins, and also to characterize and identify
microorganisms and eukaryotic cells (Zheng et al., 2018).
The high content of structural information, combined with
sensitivity, quantification, andmultiplexing opportunities, makes
SERS a very powerful technique for the demanding purposes of
nEV characterization.
Applications of SERS to nEVs
Vibrational spectroscopy without the assistance of plasmonics
(i.e., Raman and infrared spectroscopy) has been applied
to characterize nEVs and MVs in several cases, enabling
quantitative measurement of global chemical composition
analysis (e.g., relative amounts of nucleic acids, protein, lipids,
sterols, etc.). Spontaneous Raman of both bulk EVs (Tatischeff
et al., 2012; Krafft et al., 2016; Gualerzi et al., 2017) and also single
vesicles trapped by optical tweezers (Smith et al., 2015; Carney
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et al., 2017; Lee et al., 2018; Kruglik et al., 2019) can be used
to distinguish vesicles from various sources or disease contexts.
Yet, spontaneous Raman spectroscopy has limited speed, and
only relatively small numbers of EVs can be measured in a
reasonable period, dramatically limiting its potential for clinical
application. Therefore, it is more than likely necessary to exploit
plasmonics enhancement of Raman scattering (i.e., SERS) to
increase sensitivity and throughput.
SERS probes
Several SERS studies using NP probes have been recently applied.
Typically, the probes provide SERS enhancement of endogenous
chemical nEV markers, such as lipids and membrane proteins,
that vary amongst samples of interest (Figure 13). Park et al.
applied 80 nm AuNPs to nEVs isolated by UC from two non-
small-cell lung cancer (NSCLC) lines (H1299 and H522) in
addition to normal alveolar cell line derived nEVs (Park et al.,
2017a). Following deposition of AuNPs/nEVs onto a slide, PCA
was used to classify resulting SERS spectra from 37 samples
of H1299 nEVs, 34 samples of H522 nEVs, and 23 samples
of alveolar nEVs into either NSCLC or normal groups with
95.3% sensitivity and 97.3% specificity. A variable loading plot
for PCA was created with each point representing a unique
wavenumber, allowing for greater classification sensitivity, down
to 109 particles/mL, rendering this technique more sensitive than
chemiluminescence ELISA. Our own work examined the use
of peptide-ligand decorated silver NPs (AgNPs) to capture and
analyze nEVs binding α3ß1 integrin overexpressed on OvCa cell-
derived nEVs, though should be extended to clinical samples for
increased relevance (Lee et al., 2017).
Another study utilized a non-specific coating of 10 nm
AuNPs to prepare surface-deposited nEVs for SERS interrogation
(Stremersch et al., 2016). Here, nEVs were isolated by density
gradient UC from either B16F10 melanoma cells or primary
RBCs. First, cationic AuNPs were optimized to densely coat the
anionic nEVs. DLS indicated ∼800 AuNPs per B16F10 vesicle
and ∼1,200 per RBC vesicle. SERS signals were obtained for
both samples and subjected to a partial least squares discriminant
analysis (PLS-DA) and multivariate curve resolution alternating
least squares (MCR-ALS). Both statistical models were calibrated
with spectra from AuNPs alone and AuNPs with either B16F10
or RBC vesicles. Sensitivity was found to be 98.5, 88.0, and 95.1%
and specificity was found to be 95.5, 95.4, and 98%, respectively.
To demonstrate diagnostic potential, varying ratios of B16F10-
derived and RBC-derived nEVs were mixed with AuNPs to
provide a more accurate representation of an in vivo situation
where tumor-associated vesicles are not the most abundant type.
AuNP-coated nEVs from differing cell lines were able to be
classified by biomolecular diversity by applying SERS technology
in conjunction with PLS-DA statistical analysis, demonstrating
the potential application of single vesicle identification for
diagnostic use. Furthermore, throughput was high, with as many
as 160,000 individual vesicles analyzed in a single day.
To increase chemical specificity beyond non-specific SERS
probes, other approaches have incorporated immunolabeling
techniques. One such study utilized a sandwich-based
immunoassay (Zong et al., 2016), not unlike the geometry
FIGURE 13 | SERS detection of unique Raman scattering profiles. Lung
cancer cell-derived and normal nEVs measured using AuNPs as
plasmon-active signal amplifiers for SERS. Subsequent principal component
analysis (PCA) can used to decompose acquired SERS spectra and perform
correlation analysis against profiles of potential nEV surface protein markers.
Cancerous exosome-specific protein markers are associated in terms of signal
similarity. Reprinted with permission from Shin et al. (2018) Copyright (2018)
American Chemical Society.
of a heterogeneous sandwich ELISA assay. In that study, two
types of NPs were used: a SERS nanorod with a gold core and
silver shell (Au@Ag NRs) and a magnetic nanobead, the latter
synthesized by coating an iron oxide (Fe3O4) NP with a silica
shell. Both Au@Ag NRs and magnetic nanobeads were further
decorated with antibodies, enabling formation of a sandwich
complex by capturing vesicles between the nanobeads and NRs.
The resulting magnetic properties of the immunocomplexes
permitted separation by magnet for SERS signal detection in
collected precipitates. Using anti-CD63 and anti-HER2 antibody,
nEVs secreted by SKBR3 could be readily distinguished from
control MRC5 cell-derived nEVs. Decreasing concentrations
of vesicles were immunoprecipitated to find an LOD of
∼1,200 vesicles, with a total assay time of just 2 h. Another
study incorporated three specific SERS probes decorated
with aptamers as alternative biorecognition components to
supplement antibodies (Wang et al., 2018). Here, silica coated
magnetic beads were further coated with a plasmonic gold
layer (MB@SiO2@Au) to be used as capturing substrates. CD63
surface protein aptamer was decorated onto the MB@SiO2@Au
probes. In conjunction, AuNPs with complementary specific
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aptamers (AuNP@aptamer) were developed for use as a readout
signal. Target nEVs were added to a mixture of the two probes
to form a sandwich apta-immunocomplex. Similar to the
previous study, the complexes could be precipitated by magnet
for SERS readout. In this case, the signal became weaker with
the addition of EVs that bind to the SERS probes while the
signal from control non-specific probes remain unchanged.
nEVs isolated using commercial kits from breast cancer cells
(SKBR3), PCa cells (LNCaP), and colorectal cancer cells (T84)
were each probed by various specific AuNP@aptamer complexes,
using aptamers for H2, PSMA, and CEA, respectively. As the
enhancements in various regions of SERS spectra varied widely
between the samples, each presented a unique LOD: 32 nEVs
per microliter for SKBR3, 203 nEVs per microliter for LNCaP,
and 73 nEVs per microliter for T84. A similar study fabricated
gold nanostars (AuNSs) “over-coated” with an outer gold film
to trap Raman reporter molecules (4-MBA) between the layers
(Tian et al., 2018). These AuNS@-4-MBA@Au probes were
used as detection agents to probe nEVs pulled down on larger
magnetic beads. Using a bivalent cholesterol-labeled DNA
anchor to sandwich nEVs between the magnetic beads and
plasmonic probes, reported LOD was low as 27 particles/µL.
Ultimately, the use of commercial kits and small number of
human clinical samples diminished our enthusiasm for each of
the two previous studies, yet the proof-of-concept and low LODs
are encouraging.
SERS probes have become a compelling alternative for
plasmonic nEV detection and characterization. Virtually
infinite amount of different nanofeatures can be crafted to
provoke SERS signal enhancement followed by chemical
functionalization with capturing and/or reporter compounds
(Chinen et al., 2015; Liu et al., 2017; Zhang Y, et al., 2018).
Three major aspects should however be more thoroughly
addressed to make pioneering breakthroughs to the clinical
settings. First, more rigorous testing with a large volume of
clinical samples—even in proof-of-concept studies. Second,
the development of well-validated and standardized SERS
assay kits would be necessary for eventual adoption by non-
experienced clinical operators. Third, Raman spectrometers
in general are still typically too expensive and cumbersome
for routine clinical analyses. Hand-held point-of-care
spectrometers are already paving the way for these future
diagnostic purposes.
SERS substrates
Ultimately, the use of nanoplasmonic probes may introduce
some artifacts and complications, and samples are subjected to a
number of undesirable mixing and washing steps. It is possible
to realize SERS analysis using wholly label-free approaches
with the use of active substrates, for example where plasmonic
enhancement is afforded by the same material used to capture
the biological agent of interest. Application of this concept to
nEVs was introduced using super-hydrophobic surfaces (SHSs)
in the form of patterned silicon micro-pillars decorated with
silver nano-aggregates on the pillar top (Tirinato et al., 2012).
The characteristic high hydrophobicity of these surfaces allows
diluted solutions to concentrate a small number of molecules
into a tiny region for analysis. Using commercial PEG isolation
kits, nEVs were isolated from a colon tumor cell line (HCT116)
and a healthy control cell line (CCD841-CoN) and diluted to
a measured total protein concentration of ∼0.2 ng/mL. Small
aliquots of the mixture were dropped upon the SHSs and
analyzed with SERS. Control nEVs showed higher intensities for
peaks that corresponded to lipid vibrations while nEVs from
the HCT116 tumor cell line showed larger SERS signals for
protein and ribonucleic acid bases peaks. The differing intensities
suggest that the two types of vesicles exhibit different biochemical
composition, potentially due to differing cargo they carry. In
another study, a large-scale SERS substrate was created from
optical disk structures coated in varying levels of silver, allowing
for tunable plasmonic resonances (Avella-Oliver et al., 2017).
The biosensing capabilities of these substrates was shown by
obtaining Raman spectra of hemoglobin and lung cancer cell
line-derived nEVs, yet limit of detection, specificity, sensitivity,
nor number of samples was reported. The authors suggest
that prospective Raman microscope units can be based on
optical disk drives to allow for transference of SERS to many
environments. Another interesting SERS substrate was recently
reported, featuring a nanohole array fabricated via electron
beam lithography in both circular and square well form with
pancreatic MSC EVs being introduced through drop casting.
Following drying, Raman spectra were measured and compared,
showing both shared spectral commonalities as well as variation
between the EVs, the latter attributed to the presence or absence
of proteins and nucleic acids. Again, however, no specificity,
sensitivity, or number of samples analyzed was reported.
We also recently demonstrated application of a novel SERS
substrate for nEV biochemical analysis (Lee et al., 2015). In
our study, PDMS nanobowls coated with a thin (40 nm) silver
film were used as SERS substrates set to capture small numbers
of vesicles. nEVs were isolated from SKOV-3 cancer cell lines
via both UC as well as with commercial TEIR for comparison.
Twenty microliter of nEV dilutions could be dropped onto
the SERS nanobowls and dried, pushing the vesicles into
close contact with the substrate surface. SERS measurements
were taken with TEIR kit solution itself, nEVs isolated via
TEIR kit, and nEVs isolated via UC. Use of the nanobowls
provided more reproducible SERS intensities because of more
consistent “hot-spots” when compared to randomly aggregated
nanoparticles used in other studies. A time-dependent analysis
of the nEVs was performed, which showed that initially the
vesicles maintain their form and the SERS signals represent
the surfaces but as time progresses and the substrates dry
out, the vesicles burst and spill their internal contents, causing
a shift in the spectra. Thus, a distinction could be made
between the surface and internal contents of the exosomes
in solution. The LOD for this method was found to be one
EV per nanobowl due to the limiting area created by the
nanobowl dimensions.
A common design is to deposit AuNPs onto a slide to
create a SERS substrate, for example using 10 nm AuNPs
on a gold-coated slide that results in many hot-spot regions
(Carmicheal et al., 2019). In that study, a cationic AuNP coating
further facilitated binding of anionic nEVs, and SERS spectra
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from lipid and proteins distinguished pancreatic cancer serum
samples from healthy controls in most patients with sensitivity
and specificity of 90.6 and 97.1%, respectively. Shin et al.
used antibody-coated 80 nm AuNPs in a similar fashion to
detect characteristic SERS bands associated with nEV chemical
content that distinguished NSCLC nEVs from healthy controls
(Figure 13) (Shin et al., 2018). A more exotic SERS substrate
was introduced by way of its strong plasmonic “gap-mode”
(Sivashanmugan et al., 2017). Here, silver nanocubes (AgNCs)
were assembled on an AuNR pillar array surface at varying
AuNR tip-to-tip distances until an optimized geometry was
found (Figure 14), i.e., resulting in the greatest amplification of
SERS signal. The platform could distinguish nEVs derived from
lung tumor cell lines (PC-9, H1975, andHCC827) compared with
normal lung cell lines (NL-20, BEAS-2B, and L929). Titrations
of nEVs were tested to show that detection was possible at
concentrations 104 to 105 times lower than that found in typical
blood samples.
While it is clear that SERS substrates with increasingly
complex geometries could be of high impact for highly
sensitive, minimally-invasive clinical diagnostics, there is a
major drawback of the approach. It is not clear whether the
intensity of SERS signals can be attributed to an increase in
analyte concentration or rather that analyte is located at a
more favorable position in the electromagnetic field or “hot
spot,” thus quantitative measurements are far more difficult to
obtain. New approaches will be needed to address this, e.g.,
via tunable site-specific binding to SERS probes and substrates.
Another challenging aspect for this approach is to refine
appropriate protocols for preparing substrate surfaces to ensure
reproducible measurement, avoid non-specific absorption, and
to attract EVs without the addition of bulky capture agents
that interfere with the required spatial proximity of EV
to surface.
FUTURE OUTLOOK
Applicability of Emerging Technologies
While this review provides a comprehensive summary on
applications of nanoplasmonic techniques to analyze nEVs, we
acknowledge that the journey is just beginning. Novel and
creative approaches in the fields of nano and materials sciences,
plasmonics, and optics will continue to improve nEV research.
Even incremental modifications can be made to improve
biosensor sensitivity in SPRS, such as by harnessing plasmonic
coupling effects using plasmonic NPs (Špringer et al., 2014).
Strongly absorbing dye molecules have also been used to enhance
sensitivity and selectivity for an SPRS-based DNA hybridization
assay (Granqvist et al., 2013), as have two-dimensional transition
metal dichalcogenides (TMDCs) and graphene heterostructures
(Zhao et al., 2018).
Many other emerging tools may have plasmonic applications
as well. Surprisingly, IR spectroscopy has not gained a
solid foothold amongst nEV characterization methods
outside of a few notable examples (Mihály et al., 2017). As
a future endeavor, surface enhanced infrared absorption
spectroscopy (SEIRAS) could be exploited to amplify IR signal
(Ataka and Heberle, 2007).
A nanomechanical resonator was recently demonstrated
to weight the mass of single NPs down to 10 nm with
attogram precision (Olcum et al., 2014). It is likely that select
subpopulations could be identified using plasmonic adaptations.
Oliveira-Rodrígues and co-workers developed a lateral flow
immunoassay (LFIA) in a dipstick format using antibody-labeled
AuNPs as probes (Oliveira-Rodríguez et al., 2016). Capillary
forces induce a flow, the analytes of interest (e.g., nEVs)
interact with the immobilized specimens and detection can be
performed with a chosen probe. Being a cost-effective, fast,
simple, and suitable for non-trained operators, such LFIA tests
are especially promising for point-of-care (POC) applications.
When higher throughput is desired, miniaturized lab-on-chip
solutions with embedded microfluidics could be integrated.
Indeed, the physical features of microfluidic techniques match
very well the requirements of nEV research; negligible volumes
(10−9 to 10−18 L) of liquids are being manipulated in channels
with dimensions of tens to a few hundred microns. Furthermore,
nEV analyses can be carried out in a short time, inexpensively,
and isolation in addition to characterization is possible with
high resolution and sensitivity. Microfluidics in combination
with optics, nanoplasmonics and advanced data analysis tools
offer an immense palette of opportunities for robust, automated,
high-throughput and statistically relevant nEV research as well
as moving from bench to bedside and commercial applications.
We guide the reader to two excellent reviews that elucidate how
modern microfluidic lab-on-chip techniques can be applied for
nEV isolation, detection, and characterization (Gholizadeh et al.,
2017; Chiriacò et al., 2018).
Still other emerging tools may be boosted by nanoplasmonic
additions, such as the recent introduction of ZnO nanowire
lateral displacement arrays for nEV fractionation and enrichment
(Wunsch et al., 2016). This platform shares many features with
the plasmonic nanoarrays presented above, and it is feasible
that the physical separation obtained may be complimented by
real-time chemical analysis afforded by incorporating plasmonic
materials. Sensitivity of colorimetric approaches in general, for
example using recent ZnO nanowire nEV “traps” could be
improved using plasmonic probe detection (Chen et al., 2018).
The recent advancements using graphene as a nanoplasmonic
probe (de Abajo, 2014; Low and Avouris, 2014) has not yet
extended to nEV detection, with one exception (Zhang P, et al.,
2016). The emerging field of terahertz spectroscopy (Yang et al.,
2016) has also only been applied to nEV analysis in one case
(Knyazkova et al., 2018), yet also stands to greatly benefit
with respect to sensitivity when combined with nanoplasmonic
probes or surfaces (Gomez-Diaz et al., 2015). Finally, data
analysis will be a critical area of research for nEVs, and
we anticipate machine learning (or deep learning) to be a
necessary tool to detangle the large swaths of data across
patient samples afforded by emerging nanoplasmonic tools
(Ballard et al., 2017; Malkiel et al., 2018). As spectroscopic
and otherwise classifiable data collection rates increase, we
expect these applications to rapidly grow in the years to come
(Ko et al., 2017; Lee and Offerhaus, 2018).
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FIGURE 14 | Plasmonic gap-mode SERS substrate SERS spectra of nEVs isolated from (a) normal lung cells and (b) lung cancer cells, recorded on an optimized Ag
nanocubes on Au nanorod array (NCs-I-NRs). (c) A schematic of the showing the AgNCs embedded in the AuNR array the associated gap-mode electromagnetic
enhancement for a bound nEV. (d) SEM images of the NCs-I-NRs from top-down perspective. Reprinted from Sivashanmugan et al. (2017) with permission from
Elsevier.
Critical Challenges
Diagnostic platforms for disease-associated nEVs have so
far failed to achieve meaningful clinical translation, partly
due to confusion and difficulties regarding their isolation
and characterization, but also due to their low frequency in
circulation compared to healthy background, particularly for
early-stage patients. Nanoplasmonics offers the potential to
realize the promise of exosomes and related nEVs to non-
invasively report in real-time on the condition of cells and
tissues. It is clear that nanoplasmonics-based approaches to
detect and molecularly characterize nEVs offer spectacular
signal enhancement compared to standard field-adopted
methods. Yet, the majority of reported nanoplasmonic
approaches are firmly ground at the level of proof-of-concept,
displaying only incremental effects with limited scope. Although
rational synthesis of plasmonic materials has been advancing
tremendously in the past several years (Xi et al., 2018; Gurav
et al., 2019), next-generation systems have not yet been
realized and widespread clinical adoption is not feasible
(Scarabelli, 2018). While plasmonics-based biosensing
will certainly produce a huge impact on global health,
particularly for low resource environments, there is still
a long way to go. We summarize here several critical
challenges with respect to nEVs (e.g., isolation, sampling,
etc.) and engineering nanoplasmonic tools tailored for
their study.
SUMMARY POINTS:
1. Researchers should focus on improving statistical power in
clinically relevant sample sets, especially increasing number of
patient samples, with the goal of high-power clinical trials.
2. Adherence to the ISEV suggested minimal information to
characterize nEVs, along with careful reporting using the
EV-TRACK database is highly advisable. Specifically, care
should be taken to provide stringent chemical and physical
characterization of EV preps using complementary field-
validated methodology and protocols.
3. Development of materials engineering and chemical methods
to improve the homogeneity of plasmonic probes and
substrates is needed, the lack of which severely limits
reproducibility and system stability or predictability. The effect
of heterogeneity of nanoplasmonic probes and substrates is
rarely considered and should be measured, reported, and the
results contextualized accordingly.
4. Label-free approaches should be chosen when possible, in
order to avoid known artifacts with respect to heterogeneous
nEV labeling.
5. Plasmonic NP and substrate geometries should be tailored
toward accounting for heterogeneity in size, a hallmark of
nEVs. For example, nanohole arrays may be varied in hole
diameter to accommodate a range of EV sizes, rather than a
one-size-fits-all approach.
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6. The vast majority of assays are currently limited to detecting
transmembrane or lipid-bound biomolecules, based on
immunoaffinity of whole nEVs to device surfaces. New assays
should be developed to investigate and correlate intravesicular
content, for example, plasmonic analysis before and after
EV lysing.
7. Approaches capable of quantitative analysis, particularly
toward single vesicle measurements, are critical to interpret
and understand detailed structural and chemical information
of nEVs in in vivo context. Diffraction-limited nanoplasmonic
approaches may take advantage of patterning/spacing to
address single or small groups of vesicles in their appropriate
dimension range.
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